Hyderabad:Hyderabad has emerged as a complete healthcare and life sciences ecosystem—from drug discovery and clinical trials to world-class hospitals and affordable patient care. It hosts eight of the top ten global pharma companies, five of India’s leading healthcare chains, and over 230 USFDA-approved manufacturing facilities, said industries minister Duddila Sridhar Babu.
Speaking at the launch of Agilent Technologies’ new Biopharma Experience Centre in Hyderabad, he said Telangana is contributing nearly one-third of India’s pharmaceutical production and 40 per cent of bulk drug exports. The state is making a strong impact both nationally and globally, he said.
For Agilent, The facility marks a significant investment in Hyderabad’s rapidly growing life sciences ecosystem. “India is a strategic growth market for Agilent, and Hyderabad is at the forefront of biopharma innovation,” said CEO Padraig McDonnell
The new centre reinforces support for the Make-in-India initiative by empowering local innovation, nurturing talent, and enabling scalable, affordable, and sustainable solutions. he new Agilent centre in Hyderabad presents an opportunity to accelerate the city’s leadership in life sciences and healthcare innovation. Designed to support the full drug development journey, the centre brings together advanced lab technologies, expert training, and regulatory-ready workflows to help researchers, scientists, and companies develop medicines faster and efficiently, a release said.
